Article Information
History
- June 14, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Simson Tarigan1,*,
- Sumarningsih1,
- Gita Sekarmila1,
- Apas1,
- Ronald Tarigan2,
- Ryandini Putri1 and
- Damai Ria Setyawati3
- 1Research Center for Veterinary Sciences, Research Organization for Health, National Research and Innovation (BRIN), Cibinong, Indonesia
- 2School of Veterinary Medicine and Biomedical Sciences, IPB University, Bogor, Indonesia
- 3Research Center for Vaccine and Drugs, Research Organization for Health, National Research and Innovation (BRIN), Cibinong, Indonesia
- ↵*Corresponding author Simson Tarigan, Email: sitariganta{at}gmail.com
Posted June 14, 2024.
Optimization of Soluble Expression of CTA1-(S14P5)4-DD and CTA1-(S21P2)4-DD Fusion Proteins as Candidates for COVID-19 Intranasal Vaccines
